B cell-specific LMP1-transgenic mice developed LMP1-positive lymphoma triggered by aging or T cell depletion13,14, indicating LMP1 is a sufficient oncogenic factor for EBV+ B cell malignancy. This evidence concerns the gene PDLIM7 and lymphoma.